Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
The coexisting pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006
Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 311s Year: 2001
Pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 506s Year: 2006
Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Reduced moxifloxacin exposure in patients with tuberculosis and diabetes Source: Eur Respir J, 54 (3) 1900373; 10.1183/13993003.00373-2019 Year: 2019
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Diagnostic characteristics of pulmonary tuberculosis with diabetes mellitus Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002
Primary drug resistance rates in pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001